Drug Database
Back to search

France· FR:68810740

LANSOPRAZOLE ALMUS PHARMA 30 mg, gélule gastro-résistante

A lansoprazole product containing lansoprazole, registered in France by ALMUS FRANCE, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC A02BC03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedLANSOPRAZOLE ALMUS PHARMA 30 mg, gélu…ATCA02BC03REGISTER NO.FR:68810740PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lansoprazoleAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lansoprazole is registered in 19 of 19 countries.

Countries holding a registration under ATC A02BC03 (lansoprazole), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 11 of them publish a price we can compare per daily dose
Search lansoprazole products by name

Lansoprazole · ATC A02BC03

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lansoprazole costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.15 in France to $0.75 in Switzerland — a ×5.2 gap.

  • France: $0.15 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Lansoprazole · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.75
  • ES Spain$0.32
  • IT Italy$0.22
  • FR France$0.15
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
LANSOPRAZOLE
Manufacturer
ALMUS FRANCE
Country
France (FR)
ATC code
A02BC03
ATC class
Lansoprazole
Defined daily dose
15 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400930106860
    plaquette(s) aluminium de 14 gélule(s)
    EUR 2.23
  • cip13
    3400930106884
    plaquette(s) aluminium de 28 gélule(s)
    EUR 4.1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

743 interactions on record for lansoprazole.

Graded by severity as the source publishes them — 24 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lansoprazole against other medicinesHow interaction checks work

Lansoprazole · interactions on record

743 records

  • 24 severe
  • 125 moderate
  • 34 minor
  • 550 info

Most severe, free to view

  • CilostazolB01AC23severe
  • NelfinavirJ05AE04severe
  • AtazanavirJ05AE08severe
  • RilpivirineJ05AG05severe

10 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lansoprazole in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lansoprazole products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Agopton, Lansobene
  • Belgium · Lansoprazol Ab, Lansoprazol Krka
  • Bulgaria · Ланзацид, Ланзопразол Екофарм
  • Cyprus · Lanso
  • Czechia · Lanxib, Lanzul
  • Germany · Lanso Tad, Lansoprazol Abz
  • Denmark · Lansoprazol "doc", Lansoprazol "viatris"
  • Estonia · Lanzostad, Lanzul
  • Spain · Duomate Flas, Estomil
  • Finland · Gasterix, Lansoprazol Krka
  • United Kingdom (Northern Ireland) · Lansoprazol Activase Pharmaceuticals, Lansoprazole
  • Greece · Lanciprol, Lanso
  • Croatia · Lanzul, Lanzul S
  • Hungary · Emillan, Lansoprazol Teva
  • Ireland · Lansoprazole Accord, Lansoprazole Accord Healthcare Ireland
  • Iceland · Lansoprazol Krka
  • Italy · Ermes, Frilans
  • Lithuania · Lanobax, Lanzostad
  • Luxembourg · Lansoprazol Ratiopharm, Lansoprazole Eg
  • Latvia · Lanzostad, Lanzul
  • Malta · Lanzol
  • Netherlands · Lansoprazol Viatris, Lansoprazole Aurobindo
  • Norway · Lansoprazol Krka, Lansoprazol Medical Valley
  • Poland · Lanzul, Lanzul S
  • Portugal · Alexin, Belmural
  • Romania · Lanzul, Levant
  • Sweden · Lansoprazol Krka, Lansoprazol Medical Valley
  • Slovenia · Lanzul
  • Slovakia · Lanzul

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4ee0b6ef-2c52-42f7-9572-e53e8cdf87ad
GET /v1/drugs/4ee0b6ef-2c52-42f7-9572-e53e8cdf87ad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68810740",
  "date_amm": "2017-10-06",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "LANSOPRAZOLE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule gastro-résistant(e)",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about lansoprazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console